companydata.dkcompanydata.dk

Center for Clinical and Basic Research A/S: Financial statements 2019

CVR: 21142743

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Center for Clinical and Basic Research A/S (CVR 21142743) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 40,638,000 and a net result of DKK -47,356,000 compared with DKK -8,696,000 the year before. That is an increase of 571% compared with the year before. The profit margin was -116.5%. Equity in the 2019 report amounted to DKK -22,342,000. The company had 28 employees in the financial year.

Revenue
DKK 40,638,000
Gross Profit
DKK -22,348,000
Profit/Loss
DKK -47,356,000
Equity
DKK -22,342,000
Total Assets
DKK 171,534,000
Employees
28

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201940.6M-22.3M-47.4M-22.3M28
20186.1M4.9M-8.7M24.8M7
20178.2M6.8M-81M31.8M7
20167.8M5.1M-3.6M117.8M7000
20156.2M--5.3M121.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Roger Dale Smith joins the board of Center for Clinical and Basic Research A/SSep 4, 2019

As of September 4, 2019, Roger Dale Smith has joined the board of directors of Center for Clinical and Basic Research A/S.

Julia Mary James joins the board of Center for Clinical and Basic Research A/SSep 4, 2019

As of September 4, 2019, Julia Mary James has joined the board of directors of Center for Clinical and Basic Research A/S.

Christopher David Neild joins the board of Center for Clinical and Basic Research A/SSep 4, 2019

As of September 4, 2019, Christopher David Neild has joined the board of directors of Center for Clinical and Basic Research A/S.

David Scott Herron leaves the board of Center for Clinical and Basic Research A/SSep 4, 2019

As of September 4, 2019, David Scott Herron has left the board of directors of Center for Clinical and Basic Research A/S.

William Hemmings Hogan leaves the board of Center for Clinical and Basic Research A/SSep 4, 2019

As of September 4, 2019, William Hemmings Hogan has left the board of directors of Center for Clinical and Basic Research A/S.

Huong Thu Kraus leaves the board of Center for Clinical and Basic Research A/SSep 4, 2019

As of September 4, 2019, Huong Thu Kraus has left the board of directors of Center for Clinical and Basic Research A/S.

Roger Dale Smith joins Center for Clinical and Basic Research A/S as adm. dir.Sep 4, 2019

As of September 4, 2019, Roger Dale Smith is registered as adm. dir. of Center for Clinical and Basic Research A/S.

William Hemmings Hogan steps down as adm. dir. of Center for Clinical and Basic Research A/SSep 4, 2019

As of September 4, 2019, William Hemmings Hogan has stepped down as adm. dir. of Center for Clinical and Basic Research A/S.

SYNARC A/S changes name to Center for Clinical and Basic Research A/SAug 26, 2019

On August 26, 2019, the company changed its name from SYNARC A/S to Center for Clinical and Basic Research A/S.

Center for Clinical and Basic Research A/S: The 2018 annual report is outJul 9, 2019

Center for Clinical and Basic Research A/S has published its annual report for 2018. Revenue came to DKK 6,056,000, and the net result was DKK -8,696,000.

About Center for Clinical and Basic Research A/S

Center for Clinical and Basic Research A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC A/S and DODONA A/S. The management consists of Victor Richard Lopes. The board consists of Petrus Thomas Adrianus van der Zande (chair), Julia Lauren Chen and Victor Richard Lopes. The company is owned by Synexus Compass, Inc.. The company has 1 employee (2024). In 2025, the company reported revenue of DKK 2,133,368 and a net result of DKK -7,411,708 compared with DKK 10,625,435 the year before. Equity in the 2025 report amounted to DKK -16,371,637.

Source: annual report 2025, Danish Business Authority